Axa
NOVT icon

Axa’s Novanta NOVT Stock Holding History

Axa’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-338,911
Closed -$43.7M – 711
2025
Q2 		$43.7M Sell
338,911
-119,280
-26% -$14.5M 0.13% 152
2025
Q1 		$58.6M Sell
458,191
-39,296
-8% -$5.65M 0.19% 108
2024
Q4 		$76M Sell
497,487
-9,852
-2% -$1.67M 0.23% 85
2024
Q3 		$90.8M Buy
507,339
+72,543
+17% +$12.6M 0.27% 83
2024
Q2 		$70.9M Buy
434,796
+3,635
+0.8% +$590K 0.21% 105
2024
Q1 		$75.4M Sell
431,161
-9,237
-2% -$1.52M 0.23% 99
2023
Q4 		$74.2M Sell
440,398
-46,858
-10% -$6.83M 0.24% 98
2023
Q3 		$69.9M Sell
487,256
-20,315
-4% -$3.31M 0.25% 94
2023
Q2 		$93.4M Sell
507,571
-17,722
-3% -$2.9M 0.31% 80
2023
Q1 		$83.6M Sell
525,293
-4,628
-0.9% -$711K 0.29% 85
2022
Q4 		$72M Sell
529,921
-31,241
-6% -$4.37M 0.26% 103
2022
Q3 		$64.9M Sell
561,162
-12,315
-2% -$1.68M 0.26% 98
2022
Q2 		$69.5M Buy
573,477
+736
+0.1% +$92.6K 0.26% 93
2022
Q1 		$81.5M Buy
572,741
+392
+0.1% +$55.6K 0.23% 102
2021
Q4 		$101M Buy
572,349
+4,760
+0.8% +$795K 0.26% 97
2021
Q3 		$87.7M Sell
567,589
-3,233
-0.6% -$470K 0.25% 95
2021
Q2 		$76.9M Buy
570,822
+26,122
+5% +$3.52M 0.22% 109
2021
Q1 		$71.8M Buy
544,700
+68,081
+14% +$8.95M 0.22% 112
2020
Q4 		$56.3M Buy
476,619
+1,207
+0.3% +$141K 0.18% 138
2020
Q3 		$50.1M Buy
475,412
+28,818
+6% +$3.05M 0.18% 133
2020
Q2 		$47.7M Sell
446,594
-21,540
-5% -$2M 0.19% 127
2020
Q1 		$37.4M Sell
468,134
-47,701
-9% -$4.26M 0.19% 132
2019
Q4 		$45.6M Sell
515,835
-53,448
-9% -$4.61M 0.19% 135
2019
Q3 		$46.5M Buy
569,283
+116,074
+26% +$9.43M 0.19% 145
2019
Q2 		$42.7M Sell
453,209
-63,471
-12% -$5.42M 0.17% 169
2019
Q1 		$43.8M Sell
516,680
-29,365
-5% -$2.2M 0.17% 166
2018
Q4 		$34.4M Buy
+546,045
New +$35.2M 0.15% 185

Other funds holding NOVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Axa's NOVT Position: Q3 2025 in Review

Axa sold out of Novanta (NOVT) in Q3 2025, closing a stake of 338,911 shares — an estimated $43.7M sold.

Axa first reported a position in NOVT in Q4 2018 and held it in 27 quarters. The position peaked at $101M in Q4 2021. 318 funds tracked by Wall St. Rank hold NOVT as of Q3 2025.

  • Axa reported no remaining Novanta position as of Q3 2025 after selling out during the quarter.
  • Axa sold 338,911 Novanta shares in Q3 2025, an estimated $43.7M.
  • Axa first reported a position in Novanta in Q4 2018 and held it in 27 quarters.
  • Axa's Novanta position peaked at $101M in Q4 2021.
  • 318 funds tracked by Wall St. Rank held Novanta as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.